Matinas BioPharma Holdings, Inc. Matinas BioPharma Holdings, Inc.

close
  • Home
  • LNC Technology
    • LNC Platform
    • MAT2203
    • MAT2501
  • About Us
    • Company Overview
    • Leadership
    • News
  • Investors
    • Investors Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

Presentations

Investors

Investors

  • Investors Overview
  • News & Events
    • News & Events Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Company Info Overview
    • Executive Team
    • Presentations
    • Contacts
  • Financial Info
    • Financial Info Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • SEC Filings Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
Company Info

Company Info

  • Company Info Overview
  • Executive Team
  • Presentations
  • Contacts
  • Company Info

  • Company Info Overview
  • Executive Team
  • Presentations
  • Contacts
Investor Presentation
Dec 2, 2022

Investor Presentation

RSS
Matinas BioPharma Holdings, Inc.

Science

  • LNC PLATFORM
  • MAT2203
  • MAT2501

Investors

  • COMPANY PROFILE
  • STOCK DATA
  • ANALYST COVERAGE
  • GOVERNANCE
  • PRESS RELEASES
  • EVENTS
  • PRESENTATIONS
  • SEC FILINGS

Company

  • OVERVIEW
  • OUR TEAM
  • NEWS
  • CAREERS
  • CONTACT US

Register for updates

Follow Us

LinkedIn facebook twitter
© 2023 Matinas BioPharma Holdings, Inc. All Rights Reserved.